This group conducts and supports research on the prevention and early detection of breast, cervix, endometrial, and ovarian cancers. Clinical trials and the evaluation of new agents, surrogate biomarkers, and new technologies to identify premalignant lesions are developed and supported.
This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.
The group supports the ASCUS/LSIL Triage Study (ALTS), and Phase II clinical studies on breast, ovarian, cervical, and uterine cancer.
This section contains a listing of journal articles.
Mission, staff list, and contact information are in this section.
Back to top
